对外科切除结合电子束疗法对体的疗效的分析
相关实验视频
Updated: May 12, 2025

03:57
Electrochemotherapy of Tumours
Published on: December 15, 2008
24.4K
Jiaqi Zhang1, Dongjun Jeon1, Zheng Su1
1Department of Plastic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang West Road, Guangzhou, China.
Indian journal of surgical oncology
|May 8, 2025
概括
早期的电子束疗法 (手术后0-2天) 与晚期治疗 (3-5天) 相比,显著提高了 keloid 治疗的疗效. 这一发现对于优化 keloid 管理策略至关重要.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 医学物理 医学物理
背景情况:
- 状体是良性的纤维扩散性痕,可以引起显著的美容和功能问题.
- 手术切除之后的辅助疗法,如电子束疗法是常见的治疗方式.
- 优化辅助治疗的时间对于最大限度地提高治疗成功和最大限度地减少复发至关重要.
研究的目的:
- 为了研究 keloids 的发病率和患者特征对治疗结果的影响.
- 确定术后电子束疗法的时间对 keloid 治疗疗效的影响.
- 确定电子束治疗的最佳时间,以改善 keloid 管理.
主要方法:
- 对66名患者的回顾性分析,其中133名患者接受了手术和电子束治疗.
- 分析了39名患者的随访数据,以评估治疗疗效.
- 用于评估患者特征和电子束治疗时间的统计分析.
主要成果:
- 发现20-40岁的女性中,状体的发病率更高.
- 电子束疗法的时间显著影响了治疗疗效.
- 早期治疗 (手术后0-2天) 显示出比延迟治疗 (手术后3-5天) 更高的疗效.
结论:
- 术后电子束治疗的时间是成功治疗状体的关键因素.
- 在手术切除后0-2天内进行电子束疗法,可以提高治疗效率.
- 这些发现支持优化 keloids 的治疗方案,特别是关于辅助放射治疗的时间.
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.6K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.6K
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K

